Search results
AbbVie (ABBV) Gets FDA Rejection for Parkinson's Candidate
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced that FDA has issued a complete response letter (CRL) to its new drug...
AbbVie (ABBV) to Boost Immunology Pipeline With New Acquisition
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV recently announced that it has acquired UK-based private biotech, DJS Antibodies...
Can AbbVie (ABBV) Protect Revenues After Humira Patent Loss?
Zacks via Yahoo Finance· 10 months agoAbbVie’s ABBV key blockbuster immunology medicine, Humira lost patent protection in the United...
AbbVie (ABBV) Beats Q4 Earnings Estimates, Misses on Sales
Zacks via Yahoo Finance· 1 year agoAbbVie Inc. ABBV reported adjusted earnings of $3.60 per share for the fourth quarter of 2022,...
AbbVie Stock (NYSE:ABBV): Bet on a Smart Drugmaker and Dealmaker
TipRanks via Yahoo Finance· 6 months agoIs AbbVie (NYSE:ABBV) a drugmaker to wager on now? I believe it’s a very smart move to consider...
AbbVie (ABBV) Outperforms Industry This Year So Far: Here's Why
Zacks via Yahoo Finance· 2 years agoAbbVie (ABBV) has several new drugs with the potential to drive revenues once Humira loses U.S....
Will AbbVie's (ABBV) New Drugs Continue to Drive Q4 Earnings?
Zacks via Yahoo Finance· 1 year agoAbbVie’s ABBV fourth-quarter revenues are likely to be driven by revenues generated from the sales...
AbbVie (ABBV) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) second-quarter results are expected to reflect the impact of strong demand for...
AbbVie (ABBV) to Acquire Cerevel Therapeutics (CERE) for $8.7B
Zacks via Yahoo Finance· 6 months agoAbbVie ABBV has announced a definitive agreement to acquire neuroscience drugmaker, Cerevel...
AbbVie's (NYSE:ABBV) investors will be pleased with their favorable 80% return over the last three...
Simply Wall St. via Yahoo Finance· 1 year agoAbbVie Inc. (NYSE:ABBV) shareholders have seen the share price descend 13% over the month. But don't...